Skip to content

Science Not yet confirmed elsewhere1 publisher 2 min read Published

Whoop gets full Medicare payment only if patients' blood pressure, A1C and LDL improve or stay controlled

Whoop, accepted into Medicare's ACCESS program, must show better or controlled blood pressure, A1C and LDL cholesterol to be paid in full. Chief medical officer Ami Bhatt told the STAT Summit that simplifying the app comes first for patients 65 and older.

The Scientist · Science desk

How we use AI Send a correction

Photograph accompanying Whoop gets full Medicare payment only if patients' blood pressure, A1C and LDL improve or stay controlled
Photo: statnews.com

What happened

  • ACCESS is a 10-year pilot, and its directory of initial participants, published last month, lists 55 companies.
  • Each patient gets a wearable, a 12-month app subscription and access to clinicians who help them interpret their data.
  • Whoop announced clinician data-sharing this year, shortly before the FDA closed a warning letter that had called its blood pressure-estimating feature a medical device.

Why it matters

  • cost Whoop carries the risk. Bhatt described the aim as keeping the cost off the patient and placing the demand on the company.
  • constraint Payment is tied to clinical measures, so heavy app use cannot by itself earn the full amount.
  • exposure The five-millimeter blood pressure result is Bhatt's statement on stage, with no published study in STAT's account, and ACCESS will ask Whoop for results in Medicare patients.

Bhatt's case for older patients is about how easy it is to share data. Surveys suggest, she said, that even the oldest patients, the Silent Generation now past 80, trust the clinicians who treat them with their data [3]. "It's not that they're averse to giving data," she said. "It's how easy can we make it for that population to be able to share their data." [4] She put "simplification of the app" at number one on the roadmap [5]. Whoop is also working with the National Council on Aging and AARP on personalizing the product to older adults' individual priorities [6].

The payment design puts the first year on the company. "Whoop takes responsibility for, in 12 months, I am going to make these people better," Bhatt said [7]. Medicare pays the participating companies based on their health outcomes [9]. Bhatt said her role is to help a company that sold a product intentionally binned as wellness develop and demonstrate outcomes closer to clinical practice [13]. Whoop's recent $575 million raise drew investors including Mayo Clinic and Qatar's sovereign wealth fund [19].

Users check the app eight times a day on average, Bhatt said [14]. She also noted that research on continuous glucose monitors, the original wearable for diabetes, suggests engagement does not necessarily translate to better health outcomes [15]. Her answer is outcomes: Whoop has shown, she said, a decrease of five millimeters of mercury in blood pressure in individuals on Whoop [22].

The thing this doesn't tell you is who those individuals were, how many there were, or what they were compared with. STAT describes Whoop's customer base as mostly young and fit, and says the company has never been known for marketing to an older population [16]. If the five-millimeter result came from people like that, it is a weak forecast for Medicare patients 65 and up with high blood pressure, high cholesterol, obesity or prediabetes. We would want the age range, the denominator and a comparison group before leaning on it. STAT's account does not describe the underlying study, what the simplified app will change, or when it ships.

Bhatt also described the limits of continuous data from the exam room. "I had some really great patients who would print out binders of their wearable data," she said [17]. She said that despite her interest and the patient's engagement, the data was impossible to handle in a 20-minute visit [18].

What to watch

  • Whether Whoop publishes the study behind the five-millimeter blood pressure result, with age range and comparison group.
  • What the simplified app changes for users 65 and older, and when it ships.
  • Outcome results from ACCESS patients at the end of their first 12-month subscription year.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence40
Adoption15
Hype gap+20
Incentives60
Confidence55
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    Whoop was accepted into Medicare's ACCESS program this year as one of the first consumer wearable companies, making it available at no cost to many traditional Medicare patients 65 and up.

    Reported SupportedView cited source
  2. [2]

    To receive full payment under the ACCESS model, Whoop must show it improved or controlled measures tied to its patients' chronic conditions, including blood pressure, hemoglobin A1C and LDL cholesterol.

    Reported SupportedView cited source
  3. [3]

    Surveys suggest, according to Bhatt, that even members of the Silent Generation, who are older than 80 today, trust their clinicians with their data.

    Reported Supported Source: Ami Bhatt, Whoop chief medical officer, at the STAT SummitView cited source

Get this ledger inside ChatGPT. Ask about any of our stories and the answer brings its figure, each claim’s verdict and the sources. Free, no account.

Add to ChatGPTAdd to Claude

Sources

1 independent publisher whose own reporting we read for this story.

  1. statnews.com

    1 article · October 14, 2026

    How consumer tech company Whoop is building for Medicare patients

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

Entities

Loading related stories